top of page
  • Recruiting

Ph 2: Carfilzomib & lenalidomide-based treatment for newly diagnosed primary plasma cell leukemia

EMN12/HOVON129 Study


Phase 2: To evaluate progression-free survival in adult pPCL patients by incorporation of carfilzomib and lenalidomide in induction, consolidation, and maintenance therapy


EMN 12 HOVON 129

Carfilzomib and lenalidomide-based treatment for younger and elderly newly diagnosed primary plasma cell leukemia patients.


HOVON HO129 PCL


Multicenter, intergroup, phase 2 study

 

Carfilzomib and lenalidomide-based treatment for younger and elderly newly diagnosed primary plasma cell leukemia patients.


Start Date: 2015-08-10

Stop Date: 2023-08-10

Netherlands Trial Register - Trial NL5202 (NTR5350)


https://www.trialregister.nl/trial/5202